MedPath

Evaluation of intrauterine infusion of autologous platelet rich plasma (PRP) on in vitro fertilization (IVF)

Phase 3
Conditions
female infertility.
female infertility unspecified
Registration Number
IRCT2016090328950N2
Lead Sponsor
Shahid Sadoughi University of Medical Sciences, Vice chancellor for research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
66
Inclusion Criteria

women undergoing frozen thawed cycles; endometrial thickness less than 7 mm in 13 th day of cycle; age between 18 to 42
Exclusion criteria: hematological and immunological disorders;
hormonal disorders; chromosomal and genetic abnormalities; uterine abnormalities
(congenital or acquired)

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Endometrial thickness. Timepoint: 13th, 15th day of menstural cycle and in some patients 17th day of cycle. Method of measurement: trans vaginal sonograghy.
Secondary Outcome Measures
NameTimeMethod
Chemical pregnancy. Timepoint: 2 weeks after embryo transfer. Method of measurement: serum pregnancy test.;Clinical pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: trans vaginal sonograghy.
© Copyright 2025. All Rights Reserved by MedPath